MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome
NCT04525378
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Covid19
ARDS, Human
Interventions
OTHER:
Mesenchymal stromal cell-based therapy
Sponsor
D'Or Institute for Research and Education